Vinutha R. Bhat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vinutha R. Bhat has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Danavath Nagendra
Department of Critical Care Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
6 shared publications - Shankar M. Bakkannavar
Department of Forensic Medicine and Toxicology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
6 shared publications - Shwethapriya Rao
Department of Critical Care, Kasturba Medical College, Manipal Academy of Higher Education , Manipal
6 shared publications - Thejesh Srinivas
Department of Critical Care Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
6 shared publications - Gagana Hanumaiah
Department of Obstetrics and Gynaecology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
5 shared publications - Souvik Chaudhuri
Department of Critical Care, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
5 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Interpretable prediction of mortality in zinc phosphide poisoning using combined statistical and machine learning models: a retrospective observational study
Zinc phosphide poisoning is associated with high mortality due to rapidly evolving multi-organ dysfunction, yet reliable early risk stratification remains limited. This retrospective observational study evaluated the feasibility of combining conventional statistical modelling with interpretable machine learning (ML) for prediction of in-hospital mortality. A total of 290 adults with confirmed zinc phosphide poisoning admitted to a tertiary care hospital between January 2016 and November 2022 were included. In-hospital mortality occurred in 88 patients (30.3%). Demographic, physiological, and laboratory variables recorded within the first 48 h of hospitalization were analysed. Multivariable logistic regression was performed to identify independent predictors of mortality. Subsequently, ML models (logistic regression, Random Forest, and Extreme Gradient Boosting [XGBoost]) were developed using repeated stratified cross-validation, and model discrimination was assessed using the area under the receiver operating characteristic curve (AUROC), calibration analysis, and bootstrap-derived confidence intervals. Explainable artificial intelligence using SHapley Additive exPlanations (SHAP) was applied to the best-performing model. Serum lactate remained the only independent predictor of in-hospital mortality in the multivariable logistic regression analysis. Among the ML models, XGBoost achieved the highest numerical AUROC (0.745; 95% confidence interval, 0.680–0.807), although differences between models (DeLong’s test) were not statistically significant. SHAP analysis identified bicarbonate, lactate, potassium, creatinine, and activated partial thromboplastin time as the largest contributors to the mortality predictions generated by the optimized XGBoost model. These findings suggest that interpretable ML may complement conventional regression by providing transparent, individualized mortality prediction while preserving clinical interpretability. However, these exploratory findings require prospective multicentre validation before routine clinical implementation.
- 6 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessInterpretable prediction of mortality in zinc phosphide poisoning using combined statistical and machine learning models: a retrospective observational study
Zinc phosphide poisoning is associated with high mortality due to rapidly evolving multi-organ dysfunction, yet reliable early risk stratification remains limited. This retrospective observational study evaluated the feasibility of combining conventional statistical modelling with interpretable machine learning (ML) for prediction of in-hospital mortality. A total of 290 adults with confirmed zinc phosphide poisoning admitted to a tertiary care hospital between January 2016 and November 2022 were included. In-hospital mortality occurred in 88 patients (30.3%). Demographic, physiological, and laboratory variables recorded within the first 48 h of hospitalization were analysed. Multivariable logistic regression was performed to identify independent predictors of mortality. Subsequently, ML models (logistic regression, Random Forest, and Extreme Gradient Boosting [XGBoost]) were developed using repeated stratified cross-validation, and model discrimination was assessed using the area under the receiver operating characteristic curve (AUROC), calibration analysis, and bootstrap-derived confidence intervals. Explainable artificial intelligence using SHapley Additive exPlanations (SHAP) was applied to the best-performing model. Serum lactate remained the only independent predictor of in-hospital mortality in the multivariable logistic regression analysis. Among the ML models, XGBoost achieved the highest numerical AUROC (0.745; 95% confidence interval, 0.680–0.807), although differences between models (DeLong’s test) were not statistically significant. SHAP analysis identified bicarbonate, lactate, potassium, creatinine, and activated partial thromboplastin time as the largest contributors to the mortality predictions generated by the optimized XGBoost model. These findings suggest that interpretable ML may complement conventional regression by providing transparent, individualized mortality prediction while preserving clinical interpretability. However, these exploratory findings require prospective multicentre validation before routine clinical implementation.
- Open Access
- 10 July 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Immunometabolic reprogramming and mitochondrial dysfunction in acute respiratory distress syndrome: mechanisms, metabolic resilience, and therapeutic perspectives- a narrative review
Background: Acute respiratory distress syndrome (ARDS) is a biologically heterogeneous condition in which patients exposed to similar injurious stimuli often develop markedly different clinical trajectories and outcomes. While inflammation is central to ARDS pathogenesis, inflammatory burden alone does not fully explain the variability in disease progression, treatment response, or recovery. Emerging evidence suggests that immunometabolic reprogramming, characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and altered metabolite signalling, plays a critical role in shaping immune-cell activation, inflammatory persistence, and tissue repair during critical illness. Main body: This narrative review synthesizes current evidence linking immunometabolic reprogramming and mitochondrial dysfunction to the clinical heterogeneity observed in ARDS. During acute lung injury, immune and structural lung cells undergo metabolic shifts characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and accumulation of bioactive metabolites such as lactate, succinate, and extracellular adenosine triphosphate (ATP). Beyond reflecting metabolic stress, these metabolites function as signalling mediators that are associated with amplified inflammatory pathways, compromised alveolar-capillary barrier integrity, and sustained lung injury. Multi-omic studies further demonstrate that distinct metabolic signatures are associated with ARDS phenotypes, disease severity, and treatment responsiveness. We integrate these findings within the concept of metabolic resilience, defined as the host’s capacity to restore coordinated mitochondrial function, redox balance, and substrate utilization following inflammatory stress. Therapeutic strategies aimed at preserving mitochondrial function, restoring nicotinamide adenine dinucleotide (NAD⁺) homeostasis, and modulating maladaptive immunometabolic signalling may offer new avenues for precision-based interventions in ARDS. Conclusions: Immunometabolic reprogramming and mitochondrial dysfunction represent central biological axes linking cellular bioenergetics with clinical heterogeneity in ARDS. Understanding metabolic resilience may help refine phenotyping strategies and support development of metabolism-targeted therapies aimed at improving outcomes in this complex syndrome. Clinical trial number: Not applicable.
- 10 July 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessImmunometabolic reprogramming and mitochondrial dysfunction in acute respiratory distress syndrome: mechanisms, metabolic resilience, and therapeutic perspectives- a narrative review
Background: Acute respiratory distress syndrome (ARDS) is a biologically heterogeneous condition in which patients exposed to similar injurious stimuli often develop markedly different clinical trajectories and outcomes. While inflammation is central to ARDS pathogenesis, inflammatory burden alone does not fully explain the variability in disease progression, treatment response, or recovery. Emerging evidence suggests that immunometabolic reprogramming, characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and altered metabolite signalling, plays a critical role in shaping immune-cell activation, inflammatory persistence, and tissue repair during critical illness. Main body: This narrative review synthesizes current evidence linking immunometabolic reprogramming and mitochondrial dysfunction to the clinical heterogeneity observed in ARDS. During acute lung injury, immune and structural lung cells undergo metabolic shifts characterized by increased glycolysis, impaired mitochondrial oxidative phosphorylation, and accumulation of bioactive metabolites such as lactate, succinate, and extracellular adenosine triphosphate (ATP). Beyond reflecting metabolic stress, these metabolites function as signalling mediators that are associated with amplified inflammatory pathways, compromised alveolar-capillary barrier integrity, and sustained lung injury. Multi-omic studies further demonstrate that distinct metabolic signatures are associated with ARDS phenotypes, disease severity, and treatment responsiveness. We integrate these findings within the concept of metabolic resilience, defined as the host’s capacity to restore coordinated mitochondrial function, redox balance, and substrate utilization following inflammatory stress. Therapeutic strategies aimed at preserving mitochondrial function, restoring nicotinamide adenine dinucleotide (NAD⁺) homeostasis, and modulating maladaptive immunometabolic signalling may offer new avenues for precision-based interventions in ARDS. Conclusions: Immunometabolic reprogramming and mitochondrial dysfunction represent central biological axes linking cellular bioenergetics with clinical heterogeneity in ARDS. Understanding metabolic resilience may help refine phenotyping strategies and support development of metabolism-targeted therapies aimed at improving outcomes in this complex syndrome. Clinical trial number: Not applicable.
- Open Access
- 15 April 2026
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 120, 103133
Reevaluating the role of pH in rehydration solutions for fingerprint recovery from dried fingertips: an exploratory study
- 15 April 2026
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 120, 103133
Open AccessReevaluating the role of pH in rehydration solutions for fingerprint recovery from dried fingertips: an exploratory study
- Open Access
- 28 March 2026
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 120, 103117
Impact of pesticides on Calliphoridae species: Insights into forensic entomotoxicology
- 28 March 2026
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 120, 103117
Open AccessImpact of pesticides on Calliphoridae species: Insights into forensic entomotoxicology
- Open Access
- 1 January 2026
- Published by Wiley in Veterinary Medicine International
- Vol. 2026 (1) , 9865544
Ameliorative Role of Ethanolic Nigella sativa Seed Extract in Chlorpyrifos‐Induced Neurotoxicity and Testicular Toxicity
Background and Aim: Chlorpyrifos, an organophosphate (OP) pesticide, is used worldwide in agriculture as an insecticide; its exposure has been linked to neurological disorder, endocrine disruption, cardiovascular disease, etc. Nigella sativa (NS), also known as black seed or black cumin, has been a part of traditional medicine and is used to treat a wide range of ailments from digestive and respiratory problems to topical skin disease. This study aims to investigate the potential protective role of the ethanolic seed extract of NS on chlorpyrifos‐induced neurotoxicity and testicular toxicity. Materials and Methods: A total of 36 male Wistar rats were divided into six groups, which included Group 1 as Control group, Group 2 as CPF 7.5 mg/kg, Group 3 as CPF 7.5 mg/kg + ATR 10 mg/kg, Group 4 as CPF 7.5 mg/kg + NS 2.5 mg/kg, Group 5 as CPF 7.5 mg/kg + NS 5 mg/kg, and Group 6 as CPF 7.5 mg/kg + NS 10 mg/kg. NS and CPF in their respective doses were administered orally, and ATR was given as intraperitoneal injection every day for 28 days. Neurotoxicity was assessed by measuring oxidative stress markers (malondialdehyde [MDA], a marker of lipid peroxidation), antioxidant status (reduced glutathione [GSH]), inflammatory markers (interleukin‐1β [IL‐1β]), and acetylcholinesterase (AChE) activity. Cognitive function was assessed using the Morris Water Maze test. Testicular toxicity was evaluated through sperm count and histopathology assessment. Results: The treatment with NS at a dose of 10 mg/kg showed neuroprotective effect through elevation in AChE activity, significant decrease in IL‐β levels, dose‐dependent decrease, and increase in MDA and GSH levels, respectively, and improved spatial memory as evidenced by increase in escape latency and the number of entries in the Morris water maze test. However, there was no significant effect in testicular toxicity. Conclusion: The results of the present study indicate that the ethanolic seed extract of NS has significant neuroprotective activity against CPF‐induced neurotoxicity, mainly at the dose of 10 mg/kg, as portrayed by the improvement in AChE activity and cognitive performance combined with its anti‐inflammatory effect through a decrease in IL‐1β levels and antioxidant effect through increase in GSH and reduction in MDA levels. However, the NS extract did not show any significant protective effect against CPF‐induced testicular toxicity. These results indicate the potential therapeutic role of NS in mitigating OP‐induced neurological damage, justifying further studies to elucidate its mechanisms and extended benefits.
- 1 January 2026
- Published by Wiley in Veterinary Medicine International
- Vol. 2026 (1) , 9865544
Open AccessAmeliorative Role of Ethanolic Nigella sativa Seed Extract in Chlorpyrifos‐Induced Neurotoxicity and Testicular Toxicity
Background and Aim: Chlorpyrifos, an organophosphate (OP) pesticide, is used worldwide in agriculture as an insecticide; its exposure has been linked to neurological disorder, endocrine disruption, cardiovascular disease, etc. Nigella sativa (NS), also known as black seed or black cumin, has been a part of traditional medicine and is used to treat a wide range of ailments from digestive and respiratory problems to topical skin disease. This study aims to investigate the potential protective role of the ethanolic seed extract of NS on chlorpyrifos‐induced neurotoxicity and testicular toxicity. Materials and Methods: A total of 36 male Wistar rats were divided into six groups, which included Group 1 as Control group, Group 2 as CPF 7.5 mg/kg, Group 3 as CPF 7.5 mg/kg + ATR 10 mg/kg, Group 4 as CPF 7.5 mg/kg + NS 2.5 mg/kg, Group 5 as CPF 7.5 mg/kg + NS 5 mg/kg, and Group 6 as CPF 7.5 mg/kg + NS 10 mg/kg. NS and CPF in their respective doses were administered orally, and ATR was given as intraperitoneal injection every day for 28 days. Neurotoxicity was assessed by measuring oxidative stress markers (malondialdehyde [MDA], a marker of lipid peroxidation), antioxidant status (reduced glutathione [GSH]), inflammatory markers (interleukin‐1β [IL‐1β]), and acetylcholinesterase (AChE) activity. Cognitive function was assessed using the Morris Water Maze test. Testicular toxicity was evaluated through sperm count and histopathology assessment. Results: The treatment with NS at a dose of 10 mg/kg showed neuroprotective effect through elevation in AChE activity, significant decrease in IL‐β levels, dose‐dependent decrease, and increase in MDA and GSH levels, respectively, and improved spatial memory as evidenced by increase in escape latency and the number of entries in the Morris water maze test. However, there was no significant effect in testicular toxicity. Conclusion: The results of the present study indicate that the ethanolic seed extract of NS has significant neuroprotective activity against CPF‐induced neurotoxicity, mainly at the dose of 10 mg/kg, as portrayed by the improvement in AChE activity and cognitive performance combined with its anti‐inflammatory effect through a decrease in IL‐1β levels and antioxidant effect through increase in GSH and reduction in MDA levels. However, the NS extract did not show any significant protective effect against CPF‐induced testicular toxicity. These results indicate the potential therapeutic role of NS in mitigating OP‐induced neurological damage, justifying further studies to elucidate its mechanisms and extended benefits.
- Open Access
- 8 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2596535
The utility of angiopoietin-2 and blood cell-derived biomarker indices in differentiating rapidly improving acute respiratory distress syndrome (RIARDS) phenotype from persistent-ARDS: a prospective observational study
Rapidly improving acute respiratory distress syndrome (RIARDS) is defined as normalization of oxygenation (PaO2/FiO2 >300 mmHg) within 24 h of invasive mechanical ventilation. Angiopoietin-2 (Ang-2), a marker of endothelial dysfunction, may predict acute respiratory distress syndrome (ARDS) outcomes, but its role in RIARDS is unclear. This study evaluated Ang-2 and other biomarkers for predicting RIARDS and their association with survival. In this prospective observational study (June 2023-January 2025) at a 2032-bedded tertiary centre, 193 consecutively enrolled mechanically ventilated ARDS patients were assessed. Demographic, clinical, and laboratory data were recorded on Day 1. Plasma Ang-2 was measured using a high-sensitivity ELISA. Primary outcome was RIARDS; secondary outcome was ICU survival. RIARDS occurred in 18.6% of patients, highest in mild ARDS (52.9%) versus moderate (19.2%) and severe (10.4%). Multivariable regression identified Ang-2 as an independent predictor. A cut-off of 5896 pg/mL yielded an AUC of 0.731 (sensitivity 57.3%, specificity 88.9%). Patients with Ang-2 < 5896 pg/mL were more likely to develop RIARDS (86.1% vs. 13.9%, p-value < 0.001). Kaplan-Meier analysis showed significantly better ICU survival in RIARDS. Early Ang-2 measurement may help differentiate RIARDS from persistent ARDS, enabling prognostic enrichment and personalized management.
- 8 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2596535
Open AccessThe utility of angiopoietin-2 and blood cell-derived biomarker indices in differentiating rapidly improving acute respiratory distress syndrome (RIARDS) phenotype from persistent-ARDS: a prospective observational study
Rapidly improving acute respiratory distress syndrome (RIARDS) is defined as normalization of oxygenation (PaO2/FiO2 >300 mmHg) within 24 h of invasive mechanical ventilation. Angiopoietin-2 (Ang-2), a marker of endothelial dysfunction, may predict acute respiratory distress syndrome (ARDS) outcomes, but its role in RIARDS is unclear. This study evaluated Ang-2 and other biomarkers for predicting RIARDS and their association with survival. In this prospective observational study (June 2023-January 2025) at a 2032-bedded tertiary centre, 193 consecutively enrolled mechanically ventilated ARDS patients were assessed. Demographic, clinical, and laboratory data were recorded on Day 1. Plasma Ang-2 was measured using a high-sensitivity ELISA. Primary outcome was RIARDS; secondary outcome was ICU survival. RIARDS occurred in 18.6% of patients, highest in mild ARDS (52.9%) versus moderate (19.2%) and severe (10.4%). Multivariable regression identified Ang-2 as an independent predictor. A cut-off of 5896 pg/mL yielded an AUC of 0.731 (sensitivity 57.3%, specificity 88.9%). Patients with Ang-2 < 5896 pg/mL were more likely to develop RIARDS (86.1% vs. 13.9%, p-value < 0.001). Kaplan-Meier analysis showed significantly better ICU survival in RIARDS. Early Ang-2 measurement may help differentiate RIARDS from persistent ARDS, enabling prognostic enrichment and personalized management.
- 4 December 2025
- Published by Wiley in International Endodontic Journal
- Vol. 59 (3) , 524-537
Comparing the Bioactive Effects of Ethylenediaminetetraacetic Acid and Maleic Acid on TGF ‐β1 Release From Dentine and Dental Pulp Stem Cell Activity
Aim: The success of vital pulp treatment (VPT) has been linked to the release of growth factors (GFs) from the dentine matrix, which stimulate dental pulp stem cell (DPSC) activities. Ethylenediaminetetraacetic acid (EDTA) is a commonly used chelating agent that induces the release of GFs bound in the dentine matrix. A 7% Maleic acid (MA) solution has been shown to have better smear layer removal capability and less cytotoxicity compared with 17% EDTA. However, no study has evaluated the effect of 7% MA on the release of GFs from circumpulpal dentine and subsequent DPSC behaviour. This study aimed to evaluate the effect of 17% EDTA and 7% MA conditioning of circumpulpal dentine on the release of transforming growth factor‐β1 (TGF‐β1), as well as the DPSC activities. Methodology: Dentine slices treated with phosphate‐buffered saline (PBS) acted as the control, while the experimental groups comprised 17% EDTA and 7% MA. The release of TGF‐β1 was quantified using ELISA following treatment with the experimental solutions. DPSC proliferation was evaluated with the MTT assay, cell migration was assessed through scratch wound and transwell migration assays. Osteogenic differentiation potential of DPSCs was verified using Alizarin Red staining and an alkaline phosphatase (AP) activity assay. Results: 7% MA induced the highest release of TGF‐β1 compared with 17% EDTA and PBS ( p < 0.001). 7% MA at 1/1000 dilution significantly increased DPSC proliferation compared with 17% EDTA and PBS ( p < 0.001). The scratch wound healing and transwell migration assays demonstrated superior DPSC migration in the 7% MA compared with the 17% EDTA group ( p < 0.001). Alizarin Red staining and quantification indicated the highest formation of mineralized nodules in the 7% MA compared with the 17% EDTA group ( p < 0.0001). The AP activity assay showed similar enzyme activity in 7% MA and 17% EDTA treated samples. Conclusions: Within the limitations of this study 7% MA performed better than 17% EDTA in promoting TGF‐β1 release from dentine, as well as increased DPSC responses related to cell proliferation, migration, and mineralisation. These findings indicate that 7% MA may be a promising dentine conditioning agent during VPT procedures.
- 4 December 2025
- Published by Wiley in International Endodontic Journal
- Vol. 59 (3) , 524-537
Comparing the Bioactive Effects of Ethylenediaminetetraacetic Acid and Maleic Acid on TGF ‐β1 Release From Dentine and Dental Pulp Stem Cell Activity
Aim: The success of vital pulp treatment (VPT) has been linked to the release of growth factors (GFs) from the dentine matrix, which stimulate dental pulp stem cell (DPSC) activities. Ethylenediaminetetraacetic acid (EDTA) is a commonly used chelating agent that induces the release of GFs bound in the dentine matrix. A 7% Maleic acid (MA) solution has been shown to have better smear layer removal capability and less cytotoxicity compared with 17% EDTA. However, no study has evaluated the effect of 7% MA on the release of GFs from circumpulpal dentine and subsequent DPSC behaviour. This study aimed to evaluate the effect of 17% EDTA and 7% MA conditioning of circumpulpal dentine on the release of transforming growth factor‐β1 (TGF‐β1), as well as the DPSC activities. Methodology: Dentine slices treated with phosphate‐buffered saline (PBS) acted as the control, while the experimental groups comprised 17% EDTA and 7% MA. The release of TGF‐β1 was quantified using ELISA following treatment with the experimental solutions. DPSC proliferation was evaluated with the MTT assay, cell migration was assessed through scratch wound and transwell migration assays. Osteogenic differentiation potential of DPSCs was verified using Alizarin Red staining and an alkaline phosphatase (AP) activity assay. Results: 7% MA induced the highest release of TGF‐β1 compared with 17% EDTA and PBS ( p < 0.001). 7% MA at 1/1000 dilution significantly increased DPSC proliferation compared with 17% EDTA and PBS ( p < 0.001). The scratch wound healing and transwell migration assays demonstrated superior DPSC migration in the 7% MA compared with the 17% EDTA group ( p < 0.001). Alizarin Red staining and quantification indicated the highest formation of mineralized nodules in the 7% MA compared with the 17% EDTA group ( p < 0.0001). The AP activity assay showed similar enzyme activity in 7% MA and 17% EDTA treated samples. Conclusions: Within the limitations of this study 7% MA performed better than 17% EDTA in promoting TGF‐β1 release from dentine, as well as increased DPSC responses related to cell proliferation, migration, and mineralisation. These findings indicate that 7% MA may be a promising dentine conditioning agent during VPT procedures.
- Open Access
- 1 December 2025
- Published by Wiley in International Endodontic Journal
- Vol. 59 (3) , 469-476
Randomised Controlled Trial on the Additive Effect Between Calcium Hydroxide and Sodium Hypochlorite in an Inter‐Visit Root Canal Dressing
Aim: To assess whether there was an additive antimicrobial effect between calcium hydroxide (Ca(OH) 2 ) and sodium hypochlorite (NaOCl) in an inter‐visit root canal dressing. Methodology: Patients presenting with a single‐rooted tooth with pulpal necrosis and asymptomatic apical periodontitis were included in this randomised controlled single‐center clinical superiority trial with two parallel arms. Teeth were instrumented using a rotary file system and irrigated with 3% NaOCl. Subsequently, the root canals were dressed with a Ca(OH) 2 slurry that was prepared from pure Ca(OH) 2 powder mixed with either 3% NaOCl (test group) or physiological saline solution (control group). Microbial samples were obtained after accessing the root canal, after chemo‐mechanical preparation, and after the root canal dressing with the test or control slurries. A periapical fluid sample was collected after the root canal dressing removal. Samples were transferred to the microbiology lab immediately and assessed for anaerobic growth. The levels of MMP‐9 were measured using a specific enzyme‐linked immunosorbent assay. Negative to positive growth ratios were compared between groups using Fisher's exact test. Colony‐forming units (CFUs) between and within groups and MMP‐9/total protein were compared using non‐parametric tests, p < 0.05. Results: From the 110 patients recruited for this study, 48 were available for all three sampling procedures in the test (NaOCl) and 50 in the control (saline) group. All canals showed anaerobic growth initially. Chemo‐mechanical instrumentation significantly reduced CFU counts ( p < 0.001), yet all canals remained growth‐positive. After dressing with Ca(OH) 2 /NaOCl, 19 of the 48 (40%) root canals were free of growth, compared to 3 of 50 (6%) in the Ca(OH) 2 /saline group ( p < 0.001). MMP‐9/TP levels in the periapical fluid were similar when root canals were dressed with Ca(OH) 2 slurries mixed with NaOCl or saline ( p > 0.05). Conclusions: Placing a combined NaOCl/Ca(OH) 2 dressing significantly reduced the microbial load in the root canals of teeth with primary apical periodontitis compared to a conventional slurry prepared with saline solution, without causing any apparent inflammatory response in the periapical tissues. Trial Registeration: CTRI/2020/10/028484 (Clinical Trials Registry India)
- 1 December 2025
- Published by Wiley in International Endodontic Journal
- Vol. 59 (3) , 469-476
Open AccessRandomised Controlled Trial on the Additive Effect Between Calcium Hydroxide and Sodium Hypochlorite in an Inter‐Visit Root Canal Dressing
Aim: To assess whether there was an additive antimicrobial effect between calcium hydroxide (Ca(OH) 2 ) and sodium hypochlorite (NaOCl) in an inter‐visit root canal dressing. Methodology: Patients presenting with a single‐rooted tooth with pulpal necrosis and asymptomatic apical periodontitis were included in this randomised controlled single‐center clinical superiority trial with two parallel arms. Teeth were instrumented using a rotary file system and irrigated with 3% NaOCl. Subsequently, the root canals were dressed with a Ca(OH) 2 slurry that was prepared from pure Ca(OH) 2 powder mixed with either 3% NaOCl (test group) or physiological saline solution (control group). Microbial samples were obtained after accessing the root canal, after chemo‐mechanical preparation, and after the root canal dressing with the test or control slurries. A periapical fluid sample was collected after the root canal dressing removal. Samples were transferred to the microbiology lab immediately and assessed for anaerobic growth. The levels of MMP‐9 were measured using a specific enzyme‐linked immunosorbent assay. Negative to positive growth ratios were compared between groups using Fisher's exact test. Colony‐forming units (CFUs) between and within groups and MMP‐9/total protein were compared using non‐parametric tests, p < 0.05. Results: From the 110 patients recruited for this study, 48 were available for all three sampling procedures in the test (NaOCl) and 50 in the control (saline) group. All canals showed anaerobic growth initially. Chemo‐mechanical instrumentation significantly reduced CFU counts ( p < 0.001), yet all canals remained growth‐positive. After dressing with Ca(OH) 2 /NaOCl, 19 of the 48 (40%) root canals were free of growth, compared to 3 of 50 (6%) in the Ca(OH) 2 /saline group ( p < 0.001). MMP‐9/TP levels in the periapical fluid were similar when root canals were dressed with Ca(OH) 2 slurries mixed with NaOCl or saline ( p > 0.05). Conclusions: Placing a combined NaOCl/Ca(OH) 2 dressing significantly reduced the microbial load in the root canals of teeth with primary apical periodontitis compared to a conventional slurry prepared with saline solution, without causing any apparent inflammatory response in the periapical tissues. Trial Registeration: CTRI/2020/10/028484 (Clinical Trials Registry India)
- Open Access
- 29 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Unveiling the nanotoxicology of snake venoms through functional and biochemical characterization of extracellular vesicles from Naja naja and Daboia russelii
Snake venom is a complex biochemical arsenal that exerts multifaceted effects on host physiology, primarily targeting the hemostatic, cellular, and metabolic systems. Recent attention has turned to venom-derived extracellular vesicles (EVs) as active carriers of toxin components. The current study comparatively evaluates the hematological and enzymatic effects of crude venoms and EVs from Naja naja and Daboia russelii across key physiological parameters: prothrombin time (PT), activated partial thromboplastin time (aPTT), red blood cell hemolysis, and purinergic enzyme activity (ATPase and ADPase). Both venoms and their EVs caused dose-dependent alterations in coagulation, with EVs significantly prolonging aPTT and PT, indicating intrinsic and extrinsic pathway inhibition. Hemolysis assays revealed sex-specific erythrocyte susceptibility, with higher rates observed in female samples. Additionally, venom-derived EVs modulated ATPase and ADPase activity, interfering with cellular energy metabolism and thromboregulation. Our findings establish venom EVs as potent functional units that replicate and amplify native venom toxicity. These results underscore the importance of targeting EV-associated toxins in antivenom development and highlight the evolving complexity of venom systems biology. This study broadens our understanding of venom pathophysiology and identifies novel diagnostic and therapeutic avenues against snakebite envenomation.
- 29 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessUnveiling the nanotoxicology of snake venoms through functional and biochemical characterization of extracellular vesicles from Naja naja and Daboia russelii
Snake venom is a complex biochemical arsenal that exerts multifaceted effects on host physiology, primarily targeting the hemostatic, cellular, and metabolic systems. Recent attention has turned to venom-derived extracellular vesicles (EVs) as active carriers of toxin components. The current study comparatively evaluates the hematological and enzymatic effects of crude venoms and EVs from Naja naja and Daboia russelii across key physiological parameters: prothrombin time (PT), activated partial thromboplastin time (aPTT), red blood cell hemolysis, and purinergic enzyme activity (ATPase and ADPase). Both venoms and their EVs caused dose-dependent alterations in coagulation, with EVs significantly prolonging aPTT and PT, indicating intrinsic and extrinsic pathway inhibition. Hemolysis assays revealed sex-specific erythrocyte susceptibility, with higher rates observed in female samples. Additionally, venom-derived EVs modulated ATPase and ADPase activity, interfering with cellular energy metabolism and thromboregulation. Our findings establish venom EVs as potent functional units that replicate and amplify native venom toxicity. These results underscore the importance of targeting EV-associated toxins in antivenom development and highlight the evolving complexity of venom systems biology. This study broadens our understanding of venom pathophysiology and identifies novel diagnostic and therapeutic avenues against snakebite envenomation.
- Open Access
- 18 November 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (11) , 942-953
Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis
Acute respiratory distress syndrome (ARDS) is a life-threatening condition with a high mortality rate despite advances in supportive care. Aviptadil, a synthetic analogue of vasoactive intestinal peptide (VIP), exhibits anti-inflammatory potential and cytoprotective effects that may improve pulmonary function. However, its role in improving survival among ARDS patients remains uncertain. This systematic review and meta-analysis aimed to evaluate the effectiveness of aviptadil in improving survival and oxygenation outcomes in ARDS. A comprehensive search was conducted across six databases—PubMed, Scopus, Embase, Google Scholar, Cochrane Library, and Web of Science—up to October 2025. Two investigators independently screened eligible studies. Descriptive synthesis and meta-analysis were performed using a random-effects model. The risk of bias (RoB) was assessed with the RoB 2 tool for randomized controlled trials (RCTs) and the Joanna Briggs Institute (JBI) tool for case series. The systematic review included nine studies (two RCTs and seven case series) with a total of 665 patients, 361 of whom received aviptadil. Meta-analysis of the two RCTs yielded a pooled prevalence of survival of 0.71 [95% confidence interval (CI): 0.53–0.87]. The survival odds ratio (OR) comparing aviptadil to placebo was 1.01 (95% CI: 0.72–1.42, p = 0.93), indicating no significant benefit. Across the case series, 48 of 54 patients (88.9%) survived following aviptadil therapy, demonstrating consistent improvements in oxygenation and reductions in inflammatory markers. Aviptadil may have a physiological role in improving oxygenation and reducing inflammation in ARDS; however, current evidence does not indicate a significant survival benefit. Larger, well-designed RCTs are needed to clarify its therapeutic potential. Udupa AA, Todur P, Chaudhuri S, Gupta N, Bhat VR, Nagendra D, et al. Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(11):942–953.
- 18 November 2025
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 29 (11) , 942-953
Open AccessAviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis
Acute respiratory distress syndrome (ARDS) is a life-threatening condition with a high mortality rate despite advances in supportive care. Aviptadil, a synthetic analogue of vasoactive intestinal peptide (VIP), exhibits anti-inflammatory potential and cytoprotective effects that may improve pulmonary function. However, its role in improving survival among ARDS patients remains uncertain. This systematic review and meta-analysis aimed to evaluate the effectiveness of aviptadil in improving survival and oxygenation outcomes in ARDS. A comprehensive search was conducted across six databases—PubMed, Scopus, Embase, Google Scholar, Cochrane Library, and Web of Science—up to October 2025. Two investigators independently screened eligible studies. Descriptive synthesis and meta-analysis were performed using a random-effects model. The risk of bias (RoB) was assessed with the RoB 2 tool for randomized controlled trials (RCTs) and the Joanna Briggs Institute (JBI) tool for case series. The systematic review included nine studies (two RCTs and seven case series) with a total of 665 patients, 361 of whom received aviptadil. Meta-analysis of the two RCTs yielded a pooled prevalence of survival of 0.71 [95% confidence interval (CI): 0.53–0.87]. The survival odds ratio (OR) comparing aviptadil to placebo was 1.01 (95% CI: 0.72–1.42, p = 0.93), indicating no significant benefit. Across the case series, 48 of 54 patients (88.9%) survived following aviptadil therapy, demonstrating consistent improvements in oxygenation and reductions in inflammatory markers. Aviptadil may have a physiological role in improving oxygenation and reducing inflammation in ARDS; however, current evidence does not indicate a significant survival benefit. Larger, well-designed RCTs are needed to clarify its therapeutic potential. Udupa AA, Todur P, Chaudhuri S, Gupta N, Bhat VR, Nagendra D, et al. Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis. Indian J Crit Care Med 2025;29(11):942–953.